Please login to the form below

Not currently logged in
Email:
Password:

Celltrion

This page shows the latest Celltrion news and features for those working in and with pharma, biotech and healthcare.

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Mundipharma has strengthened its partnership with biopharmaceutical group Celltrion Healthcare by securing rights to its trastuzumab biosimilar. ... Commenting on the partnership, Man Hoon Kim, president and CEO of Celltrion Healthcare, said: “We are

Latest news

More from news
Approximately 13 fully matching, plus 107 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Infographic: RA Perceptions

    Physicians predict a four-fold increase in their use of Hospira’ s Inflectra and Celltrion’ s Remsima.

  • Biosimilars: Getting the flock to market

    Biosimilars: Getting the flock to market. The biosimilars field is about to become very crowded. Here are some Life tips on how to stand out from the herd. Biosimilars have now been with us for over 10 years. In case you haven't been paying

  • Lucid Group make the cut at the PMEAs 2017

    Lucid Group make the cut at the PMEAs 2017. We’ re enormously proud that three of our programmes have made it to the finals at the upcoming Pharmaceutical Marketing Excellence Awards! Jan Steele COO and co-founder commented, “ We are extremely

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics